These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18327989)

  • 1. Diabetic stress: new triumphs and challenges to maintain vascular longevity.
    Maiese K
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):281-4. PubMed ID: 18327989
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    J Am Coll Cardiol; 2009 Jan; 53(3):298-304. PubMed ID: 19147051
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing cardiovascular risk factors and selecting agents to successfully treat patients with type 2 diabetes mellitus.
    Baldwin MD
    J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):S2-12. PubMed ID: 21813732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus: hope or despair.
    Kumar A
    J Indian Med Assoc; 2002 Mar; 100(3):134-5. PubMed ID: 12408268
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular mechanisms of diabetic cardiovascular disease.
    Hupfeld CJ; Wong GA
    Prev Cardiol; 2002; 5(4):183-7. PubMed ID: 12417827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic complications: current challenges and opportunities.
    Nickerson HD; Dutta S
    J Cardiovasc Transl Res; 2012 Aug; 5(4):375-9. PubMed ID: 22752737
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 8. Lessons from a cardiovascular outcome trial with liraglutide in type 2 diabetes.
    Kim HJ; Kim DJ
    J Diabetes Investig; 2017 Jul; 8(4):431-433. PubMed ID: 27930863
    [No Abstract]   [Full Text] [Related]  

  • 9. Should you put all diabetic patients on statins?
    Leiter LA
    J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetes and coronary artery disease: not just a risk factor.
    Grant PJ; Cosentino F; Marx N
    Heart; 2020 Sep; 106(17):1357-1364. PubMed ID: 32499237
    [No Abstract]   [Full Text] [Related]  

  • 11. Achieving glycemic control: cornerstone in the treatment of patients with multiple metabolic risk factors.
    Spellman CW
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S8-S13. PubMed ID: 19451256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Safety of Current and Emerging Glucose-Lowering Therapies.
    Fitchett D
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S176-82. PubMed ID: 26654861
    [No Abstract]   [Full Text] [Related]  

  • 14. The Diabetes Prevention Program.
    Muniyappa R; El-Atat F; Aneja A; McFarlane SI
    Curr Diab Rep; 2003 Jun; 3(3):221-2. PubMed ID: 12762969
    [No Abstract]   [Full Text] [Related]  

  • 15. Heart disease in diabetic patients.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):372-8. PubMed ID: 16298258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.
    De Feyter HM; Praet SF; van den Broek NM; Kuipers H; Stehouwer CD; Nicolay K; Prompers JJ; van Loon LJ
    Diabetes Care; 2007 Oct; 30(10):2511-3. PubMed ID: 17626892
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes and cardiovascular disease: what have we learned in 2012?
    Cunningham GR
    Tex Heart Inst J; 2013; 40(3):290-2. PubMed ID: 23914022
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetes: a pandemic, a development issue or both?
    Colagiuri R
    Expert Rev Cardiovasc Ther; 2010 Mar; 8(3):305-9. PubMed ID: 20222807
    [No Abstract]   [Full Text] [Related]  

  • 19. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    Circulation; 2009 Jan; 119(2):351-7. PubMed ID: 19095622
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    Diabetes Care; 2009 Jan; 32(1):187-92. PubMed ID: 19092168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.